SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-23-000121
Filing Date
2023-08-09
Accepted
2023-08-09 16:04:53
Documents
1
Period of Report
2023-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1691611481.html 4  
1 FORM 4 wk-form4_1691611481.xml 4 3553
  Complete submission text file 0001439222-23-000121.txt   5015
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Washburn Theodore James Jr. (Reporting) CIK: 0001874199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 231155055